Gulf Coast Research, LLC

Baton Rouge, Louisiana 70808

0 studies enrolling now · 11 studies all time

What they study most

Acute, Uncomplicated Human Influenza, Arthritis, Autism, Autistic Disorder, Child Development Disorders, Pervasive, Gastrointestinal Diseases, Hepatitis C, Influenza, NSAID-induced Gastroduodenal Injury, Opioid-Induced Bowel Dysfunction, Osteoarthritis, Rheumatoid Arthritis

Studies at this site

• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Tanezumab in Osteoarthritis of the Hip or Knee (2) — Completed
• Extension Study Of Tanezumab In Osteoarthritis — Stopped early
• Tanezumab in Osteoarthritis of the Knee — Completed
• Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza — Stopped early
• Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury — Completed
• Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone — Completed
• A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza — Completed
• A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) — Completed
• Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection — Completed
• Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism — Status unconfirmed